Following the identification of TopIIα as a substrate of APC/CFzr, Eguren and colleagues found that the combination of proTAME (to inhibit Fzr) and etoposide (to inhibit TopIIα) displayed a synergistic effect in tumour cells [21]. Here, TOP2A is linked to neoplasm.